Remogliflozin etabonate-d7, CAS [[1233515-93-9]] Preis auf Anfrage

Produktübersicht

• Artikelname: Remogliflozin etabonate-d7, CAS [[1233515-93-9]] Preis auf Anfrage
• Artikelnummer: MCE-HY-166548S
• Hersteller Artikelnummer: HY-166548S
• Alternativnummer: MCE-HY-166548S-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: GSK189075-d7

Produktbeschreibung

Remogliflozin etabonate-d7 (GSK189075-d7) is the deuterium labeled Remogliflozin etabonate. Remogliflozin etabonate (GSK189075) is an orally active, selective and low-affinity sodium glucose cotransporter (SGLT2) inhibitor with Ki values of 1.95 µM, 2.14 µM, 43.1 µM, 8.57 µM for hSGLT2, rSGLT2, hSGLT1, rSGLT1, respectively. Remogliflozin etabonate is a proagent based on benzylpyrazole glucoside and is metabolized to its active form, Remogliflozin, in the body. Remogliflozin etabonate exhibits antidiabetic efficacy in rodent models[1].

Produkteigenschaften

• Molekulargewicht: 529.63
• CAS Nummer: [1233515-93-9]
• Formel: C26H31D7N2O9
• Target-Kategorie: Isotope-Labeled Compounds,SGLT

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Isotope-Labeled Compounds